68Ga-PSMA I&T PET/CT for primary staging of prostate cancer.

Wojciech CytawaAnna Katharina SeitzStefan KircherKazuhito FukushimaJohannes Tran-GiaAndreas SchirbelTomasz BandurskiPiotr LassMarkus KrebsWojciech PołomMarcin MatuszewskiHans-Jürgen WesterAndreas K BuckHubert KüblerConstantin Lapa

Published in: European journal of nuclear medicine and molecular imaging (2019)

In patients with initial diagnosis of intermediate- and high-risk prostate cancer, 68Ga-PSMA I&T PET/CT emerges as a relevant staging procedure by identifying nodal and/or distant metastases. Due to the low prevalence of extraprostatic disease, its value seems to be limited in low-risk disease.

Keyphrases

pet ct
prostate cancer
radical prostatectomy
positron emission tomography
lymph node
risk factors
minimally invasive
computed tomography
neoadjuvant chemotherapy